Please use this identifier to cite or link to this item: http://library.ediindia.ac.in:8181/xmlui//handle/123456789/9038
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGujarat State Biotechnology Mission
dc.date.accessioned2019-07-15T13:16:08Z
dc.date.available2019-07-15T13:16:08Z
dc.date.issued2006
dc.identifier.urihttp://library.ediindia.ac.in:8181/xmlui//handle/123456789/9038
dc.language.isoenen_US
dc.publisherGujarat Department of Science and Technologyen_US
dc.subjectAnti-CD40 antibodyen_US
dc.subjectanti·MHC class II monoclonal antibodiesen_US
dc.subjectTh·2 Typeen_US
dc.subjectFlu vaccinesen_US
dc.subjectTherapeutics & Vaccinesen_US
dc.subjectPharmaceutical and Healthcareen_US
dc.subjectGSBTMen_US
dc.titleIdentification and uses of an Immunoadjuvant-enhanced, Immunotargeted Vaccine Therapyen_US
dc.typeOtheren_US
Appears in Collections:Vol. III - Pharmaceutical and Healthcare

Files in This Item:
File Description SizeFormat 
3-186.pdf
  Restricted Access
1.05 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.